Healthcare News 22 December 2025

Molina Healthcare stock rises again after Michael Burry touts insurer; Feb. 5 earnings in focus

NEW YORK, December 31, 2025, 10:30 ET — Regular session Molina Healthcare Inc shares were up 2.1% at $174.33 by 10:30 a.m. ET on Wednesday, after trading between $170.03 and $176.33 earlier in the session. The move matters because Molina

31 December 2025

Earnings Reports·Financial Analysis·Healthcare·Investment News·Stock Market

Hims & Hers stock dips in premarket as GLP-1 drug pricing pressure stays in focus

NEW YORK, December 31, 2025, 05:39 ET — Premarket Shares of Hims & Hers Health Inc (HIMS) fell 0.5% to $32.87 in premarket trading on Wednesday after closing down 3.1% at $33.04 in the prior session. The stock has traded

31 December 2025

Business News·Healthcare·Investment Analysis·Pharmaceuticals·Stock Market

UnitedHealth stock rises today as UNH outperforms peers ahead of Fed minutes, Jan. 27 results

NEW YORK, December 30, 2025, 11:18 ET — Regular session UnitedHealth Group Incorporated shares rose about 1.3% to $333.32 in late-morning trade on Tuesday, after swinging between $329.18 and $336.03. Humana gained about 0.5%, Elevance Health and Cigna edged higher,

30 December 2025

Earnings Reports·Financial News·Healthcare·Investing·Stock Market

Novo Nordisk halves Wegovy prices in parts of China as copycat competition looms

NEW YORK, December 29, 2025, 22:14 ET Novo Nordisk said it is lowering prices of its top-selling obesity drug Wegovy in China, after local outlet Yicai reported that list prices for the two highest doses were cut by 48% in

30 December 2025

Business News·Drug Pricing·Healthcare·Pharmaceuticals

Gilead stock nudges up after Bernstein flags limited Medicaid pricing hit

NEW YORK, December 29, 2025, 22:17 ET — Market closed Gilead Sciences (GILD.O) shares were last up 0.15% at $124.91 on Monday, as investors weighed an analyst note that argued new Medicaid drug-pricing rules would have a limited financial impact

30 December 2025

Healthcare·Investment·Market News·Pharmaceuticals·Stocks

UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance

NEW YORK, December 29, 2025, 10:11 ET — Regular session UnitedHealth Group Incorporated shares edged lower on Monday after a Wall Street Journal investigation said mail-order pharmacies owned by major insurers, including UnitedHealth, dispensed billions of dollars of excess prescription

29 December 2025

Business News·Healthcare·Market Trends·Stocks

Hims & Hers stock slides into year-end as investors weigh Ohio buildout and macro calendar

NEW YORK, December 29, 2025, 01:59 ET — Market closed. Hims & Hers Health Inc shares last closed down about 1% at $34.31 on Friday, extending a four-session slide as U.S. markets headed into the final trading days of the

29 December 2025

Business News·Financial Analysis·Healthcare·Investing·Stock Market

Healthcare Stocks Today: Weekend Headlines, 2026 Themes, and What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 1:22 p.m. ET — Market closed (weekend). U.S. equity markets are shut for the weekend, but healthcare stocks are heading into Monday’s session with a fresh mix of catalysts—policy scrutiny around pharmacy practices, late-year sector

28 December 2025

Financial News·Healthcare·Investment·Market Analysis·Stock Market

Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms

Dec. 25, 2025 — Abbott Laboratories (NYSE: ABT) heads into the year-end stretch with a rare mix of near-term product momentum and headline-level risk management. Over the past several weeks—culminating in key December announcements—Abbott has (1) secured U.S. FDA approval

25 December 2025

Business News·FDA Approvals·Healthcare·Medical Technology·Stock Market

Healthcare Stocks Outlook (Dec. 25, 2025): Wegovy Pill Breakthrough, FDA Approvals, and a New Wave of M&A Heading Into 2026

December 25, 2025 — U.S. markets are closed for Christmas, but healthcare stocks are ending the year with a burst of sector-defining catalysts: a landmark oral GLP‑1 approval for weight loss, multiple FDA green lights that moved biotech names sharply,

25 December 2025

FDA Approvals·Healthcare·Mergers & Acquisitions·Stocks

UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

December 22, 2025 — UnitedHealth Group Incorporated (NYSE: UNH) is ending the year with investors focused less on “normal” quarterly momentum and more on a three-part storyline that could shape how the market values the healthcare giant in 2026: (1)

22 December 2025

Corporate News·Financial Analysis·Healthcare·Regulatory Updates·Stock Market

UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth Group Incorporated (NYSE: UNH) heads into the Monday, Dec. 22, 2025 U.S. market open with investors balancing a fresh company-led audit update against a busy regulatory and legal backdrop spanning Medicare Advantage, Optum Rx, and ongoing litigation. Friday’s close

22 December 2025

Earnings Reports·Financial Analysis·Healthcare·Investment Strategies·Stock Market

Healthcare News 22 December 2025 - 31 December 2025